Circulation, Vol 85, 2236-2246, Copyright © 1992 by American Heart Association
HE Shubeita, J Thorburn and KR Chien
BACKGROUND. Microinjection approaches in the cardiac cell context have
allowed delivery of various calcium dyes and monitoring of short-term
physiological responses. However, unlike other cell types, it has proved
difficult to microinject myocardial cells without the concomitant loss of
long-term cell viability. METHODS AND RESULTS. An analysis of experimental
variables was conducted to adapt microinjection techniques to the neonatal
rat ventricular cell context. Among the variables optimized were the
selection of culture dishes, plating substrate, microinjection parameters,
and a variety of maneuvers to inhibit myocyte hypercontracture, injury, and
consequent death after micropuncture. With the modified technique, the
percentage of injected cells that maintained long-term viability (48 hours)
increased from less than 1% to 30%. Similarly, an increased efficiency of
gene transfer and expression (measured as the percentage of injected cells
that express the delivered gene) was obtained after either cytoplasmic or
nuclear injection of a beta-galactosidase expression vector into cardiac
myocytes. Microinjection of marker immunoglobulin G does not interfere with
the induction of the hypertrophic response or the expression of a
coinjected atrial natriuretic factor promoter- luciferase reporter fusion
gene construct. CONCLUSIONS. To the best of our knowledge, this study
provides the first description of the efficient microinjection of neonatal
cardiac muscle cells with maintenance of long-term cell viability. The
microinjection technique is now a viable approach to examine
cause-and-effect relations between specific gene products and any defined
feature or response of cardiac myocytes that can be assayed at a
single-cell level.
ARTICLES
Microinjection of antibodies and expression vectors into living myocardial cells. Development of a novel approach to identify candidate genes that regulate cardiac growth and hypertrophy
Department of Medicine, University of California San Diego, La Jolla 92093-0613.
This article has been cited by other articles:
![]() |
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Hakim, L. A. DiMichele, J. T. Doherty, J. W. Homeister, H. E. Beggs, L. F. Reichardt, R. J. Schwartz, J. Brackhan, O. Smithies, C. P. Mack, et al. Conditional Deletion of Focal Adhesion Kinase Leads to Defects in Ventricular Septation and Outflow Tract Alignment Mol. Cell. Biol., August 1, 2007; 27(15): 5352 - 5364. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bony, S. Roche, U. Shuichi, T. Sasaki, M. A. Crackower, J. Penninger, H. Mano, and M. Puceat A Specific Role of Phosphatidylinositol 3-Kinase {gamma}: A Regulation of Autonomic Ca2+ Oscillations in Cardiac Cells J. Cell Biol., February 19, 2001; 152(4): 717 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruiz-Meana, D. Garcia-Dorado, B. Hofstaetter, H. M. Piper, and J. Soler-Soler Propagation of Cardiomyocyte Hypercontracture by Passage of Na+ Through Gap Junctions Circ. Res., August 6, 1999; 85(3): 280 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Richards, M. Jaconi, G Vassort, and M Puceat A spliced variant of AE1 gene encodes a truncated form of Band 3 in heart: the predominant anion exchanger in ventricular myocytes J. Cell Sci., January 5, 1999; 112(10): 1519 - 1528. [Abstract] [PDF] |
||||
![]() |
R. Wessely, A. Henke, R. Zell, R. Kandolf, and K. U. Knowlton Low-Level Expression of a Mutant Coxsackieviral cDNA Induces a Myocytopathic Effect in Culture : An Approach to the Study of Enteroviral Persistence in Cardiac Myocytes Circulation, August 4, 1998; 98(5): 450 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S Mitcheson, J. C Hancox, and A. J Levi Cultured adult cardiac myocytes: Future applications, culture methods, morphological and electrophysiological properties Cardiovasc Res, August 1, 1998; 39(2): 280 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Sussman, S. Baque, C.-S. Uhm, M. P. Daniels, R. L. Price, D. Simpson, L. Terracio, and L. Kedes Altered Expression of Tropomodulin in Cardiomyocytes Disrupts the Sarcomeric Structure of Myofibrils Circ. Res., January 23, 1998; 82(1): 94 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Johnson, M. O. Gray, J. S. Karliner, C.-H. Chen, and D. Mochly-Rosen An Improved Permeabilization Protocol for the Introduction of Peptides Into Cardiac Myocytes: Application to Protein Kinase C Research Circ. Res., December 1, 1996; 79(6): 1086 - 1099. [Abstract] [Full Text] |
||||
![]() |
B. W. Doble, Y. Chen, D. G. Bosc, D. W. Litchfield, and E. Kardami Fibroblast Growth Factor-2 Decreases Metabolic Coupling and Stimulates Phosphorylation as Well as Masking of Connexin43 Epitopes in Cardiac Myocytes Circ. Res., October 1, 1996; 79(4): 647 - 658. [Abstract] [Full Text] |
||||
![]() |
R. Ross, S Navankasattusas, R. Harvey, and K. Chien An HF-1a/HF-1b/MEF-2 combinatorial element confers cardiac ventricular specificity and established an anterior-posterior gradient of expression Development, January 6, 1996; 122(6): 1799 - 1809. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |